Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Healthy × Rosuvastatin Calcium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Healthy Participants 5 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Healthy Volunteers 2 Breast Neoplasms 2 cMET-dysregulated Advanced Solid Tumors 1 TP53 Y220C Mutation 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Pain 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Healthy Adult Participants 1 Healthy 1 Drug-drug Interaction,SHR3680 1 Colorectal Neoplasms 1 Chronic Cough 1 Carcinoma, Squamous Cell 1 Advanced Solid Tumor 1 Advanced Solid Malignancies 1 Advanced Non-small Cell Lung Cancer 1

Interventions

pimodivir 1 Sunitinib 1 Rosuvastatin Calcium 1 Midazolam 1 Cyclosporine 1 Adalimumab 1 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02300363 2015-07-09

DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin

Lexicon Pharmaceuticals

Phase 1 Completed

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡